News

As per the agreement, Ironwood will develop and commercialize Bionomics’ investigational anti-anxiety compound BNC210 and other related compounds. Under the collaboration, Bionomics may receive up to $345m in

The company will also adopt Cegedim Relationship Management’s OneKey, the global healthcare professional (HCP) database, and insightful Mobile Intelligence Analytics. Pharmaceutical CRM Solution is believed to deliver Operational

Berinert is a pasteurized, nanofiltered therapy indicated for the treatment of acute attacks of hereditary angioedema (HAE), a rare and potentially fatal genetic disorder. According to the company,

Halaven is a non-taxane, microtubule dynamics inhibitor that is a synthetic analog of halichondrin B, a natural product that was isolated from the marine sponge Halichondria okadai. Halaven

As per the agreement Servier will engage BioInvent to screen its proprietary n-CoDeR library for antibodies specific to the undisclosed target. Servier will also have access to BioInvent’s

The 390-patient study will compare the safety and effectiveness of HA-Irinotecan with irinotecan in a double blind trial in second and third line metastatic colorectal cancer patients (mCRC).

MacuCLEAR has also entered into a strategic partnership with a Pacific Rim pharmaceutical partner and investor to finance clinical costs, bridging studies and regulatory development for MC-1101 in

Genentech will make use of Vernalis’ fragment and structure-based drug discovery platform against an undisclosed target. Vernalis CEO Ian Garland said the company is happy that Genentech chose

As per the agreement Vifor Pharma is granted an exclusive license for the Isotechnika’s drug, voclosporin, to treat lupus and all proteinuric nephrology indications (the Vifor Pharma License).